Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis

MA Shah, SM Abuzar, K Ilyas, I Qadees, M Bilal… - Chemico-biological …, 2023 - Elsevier
Despite the existence of extensive clinical research and novel therapeutic treatments,
cancer remains undefeated and the significant cause of death worldwide. Cancer is a …

[HTML][HTML] Emerging biomarker-guided therapies in prostate cancer

JE Deluce, L Cardenas, AK Lalani, S Maleki Vareki… - Current oncology, 2022 - mdpi.com
Prostate cancer remains one of the leading causes of cancer death in men worldwide. In the
past decade, several new treatments for advanced prostate cancer have been approved …

Defining disease-related modules based on weighted miRNA synergistic network

C Li, P Dou, T Wang, X Lu, G Xu, X Lin - Computers in Biology and …, 2023 - Elsevier
MicroRNAs (miRNAs) play an important role in the biological process. Their expression and
functional changes have been observed in most cancers. Meanwhile, there exists …

[HTML][HTML] Addressing the reciprocal crosstalk between the AR and the PI3K/AKT/mTOR signaling pathways for prostate cancer treatment

F Raith, DH O'Donovan, C Lemos, O Politz… - International Journal of …, 2023 - mdpi.com
The reduction in androgen synthesis and the blockade of the androgen receptor (AR)
function by chemical castration and AR signaling inhibitors represent the main treatment …

[HTML][HTML] Interplay of Developmental Hippo–Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer

I Mourkioti, A Angelopoulou, K Belogiannis, N Lagopati… - Cells, 2022 - mdpi.com
Prostate cancer belongs in the class of hormone-dependent cancers, representing a major
cause of cancer incidence in men worldwide. Since upon disease onset almost all prostate …

[HTML][HTML] Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer

M Wylaź, A Kaczmarska, D Pajor, M Hryniewicki… - Biomedicine & …, 2023 - Elsevier
Breast cancer (BC) and prostate cancer (PC) are at the top of the list when it comes to the
most common types of cancers worldwide. The phosphatidylinositol 3-kinase (PI3K)/protein …

[HTML][HTML] The role of erα and erβ in castration-resistant prostate cancer and current therapeutic approaches

NES Jefferi, AA Shamhari, NKZ Noor Azhar, JGY Shin… - Biomedicines, 2023 - mdpi.com
Castration-resistant prostate cancer, or CRPC, is an aggressive stage of prostate cancer
(PCa) in which PCa cells invade nearby or other parts of the body. When a patient with PCa …

[HTML][HTML] Plasmatic MicroRNAs and treatment outcomes of patients with metastatic castration-resistant prostate Cancer: a hospital-based Cohort Study and in Silico …

J Silva, V Tavares, A Afonso, J Garcia… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) is one of the most common malignancies among men worldwide.
Inevitably, all advanced PCa patients develop metastatic castration-resistant prostate cancer …

[HTML][HTML] Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers

KS Shan, A Bonano-Rios, NWY Theik… - International Journal of …, 2024 - mdpi.com
The dysregulation of the phosphatidylinositol-3-kinase (PI3K) pathway can lead to
uncontrolled cellular growth and tumorigenesis. Targeting PI3K and its downstream …

[HTML][HTML] Mechanisms of prostate cancer cells survival and their therapeutic targeting

T Pejčić, Z Todorović, S Đurašević… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) is today the second most common cancer in the world, with almost
400,000 deaths annually. Multiple factors are involved in the etiology of PCa, such as older …